59
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Rhabdophis tigrinus IN JAPAN: PATHOGENESIS OF ENVENOMATION AND PRODUCTION OF ANTIVENOM

, Director Emeritus, Japan Snake Institute, , , Former Director, Japan Snake Institute, &
Pages 181-201 | Published online: 06 Dec 2002
 

Abstract

The yamakagashi (Rhabdophis tigrinus), a colubrid snake, is common in Japan. However, largely because the snake is rear-fanged, severe bites occur rarely, and only 29 cases of yamakagashi bites have been reported since 1917. The epidemiological analysis of the severe bites indicates that most of the bites occurred in warmer months, from April to October. Most of the bites occurred in males trying to catch snakes while in residence, in the field and on the road during daylight hours. Systemic symptoms including continuous bleeding from the bite wound, gums, hematuria, ecchymosis of the body, and coagulation abnormalities of the blood are induced by a hemorrhagic factor and prothrombin activator found in the venom; fatalities occur rarely. An antivenom was produced by immunizing rabbits and goats with yamakagashi venom. The γ-globulin separated from the blood of immunized animals (antivenom) was effective at preventing hemorrhage and coagulation abnormalities of the blood of envenomated patients.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,628.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.